Correlation of Lipid Profile and Apolipoprotein B/A-I Ratio with Insulin Resistance in Non-Diabetes Mellitus Subjects

Authors

  • Andi Heriadi Palloge Master of Biomedical Sciences, Graduate School of Hasanuddin University, Makassar
  • Liong Boy Kurniawan Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar
  • Yuyun Widyaningsih Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar
  • Husaini Umar Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Makassar
  • Nurahmi Nurahmi Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar
  • Andi Alfian Zainuddin Department of Public Health, Hasanuddin University, Makassar

DOI:

https://doi.org/10.24293/ijcpml.v30i1.2198

Keywords:

Obesity, insulin resistance, lipid profile ratio, Apo B/Apo A-I ratio

Abstract

Obesity is defined as an increase in total body mass due to excess fat, as measured by the body mass index. Obesity affects metabolism through factors such as insulin resistance, which triggers the development of chronic diseases. Lipid and ApoB/ApoA-I ratios can be considered additional assessments, especially in patients at high risk of cardiovascular diseases such as diabetes. This study aims to determine the relationship between lipid and ApoB/ApoA-I ratios with Homa-IR in in non-diabetes mellitus adult subjects. The method used in this study was a cross-sectional study involving a total of 80 non-diabetic adult subjects, consisting of 38 male and 42 female subjects. The results showed that there were significant differences between the ratios of CHOL/HDL, TG/HDL, ApoB/ApoA-I, and HOMA-IR in non-obese and obese non-DM adult subjects (4.64 ± 2.18 vs 5.23 ± 1.87, p = 0.045; 2.38 ± 1.20 vs. 3.18±1.77, p=0.013;0.58±0.17 vs. 0.66±0.17, p=0.035 and 1.47±0.80 vs. 3.34±4.37, p = 0.000), and there was no significant difference between LDL/HDL (p = 0.117). The correlation test results between the ratios of CHOL/HDL to HOMA-IR, LDL/HDL to HOMA-IR, TG/HDL to HOMA-IR, and ApoB/ApoA-I to HOMA-IR in non-DM adult subjects (p=0.05, r=0.308; p=0.037, r=0.233; p=0.000, r=0.402; p=0.19, r=0.261). This study concluded that there was a significant correlation between lipid and ApoB/ApoA-I ratios with Homa-IR in non-diabetes mellitus adult subjects.

Downloads

Download data is not yet available.

Author Biographies

Liong Boy Kurniawan, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi

Yuyun Widyaningsih, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi

Husaini Umar, Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Makassar

Department of Internal Medicine, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi

Nurahmi Nurahmi, Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar

Department of Clinical Pathology, Faculty of Medicine, Hasanuddin University, Makassar, South Sulawesi, Indonesia

Andi Alfian Zainuddin, Department of Public Health, Hasanuddin University, Makassar

Department of Public Health, Hasanuddin University, Makassar, South Sulawesi

References

Rassy N, Van Straaten A, Carette C, Hamer M, Rives-Lange C, Czernichow S. Association of healthy lifestyle factors and obesity-related diseases in adults in the UK. JAMA Netw Open, 2023; 6(5): e2314741.

Galuppo B, Umano GR, Li Z, Li Zhongyao, Name MH, et al. Comparison of metabolic response to colonic fermentation in lean youth vs. youth with obesity. JAMA Netw Open, 2023; 6(5): e2312530.

Safaei M, Sundararajan EA, Driss M, Boulila W, Shapi'i A. A systematic literature review on obesity: Understanding the causes & consequences of obesity and reviewing various machine learning approaches used to predict obesity. Comput Biol Med, 2021; 136: 104754.

Lin X, Li H. Obesity: Epidemiology, Pathophysiology, and Therapeutics. Front Endocrinol (Lausanne), 2021; 12: 706978.

Jin X, Qiu T, Li L, Yu R, Chen X, et al. Pathophysiology of obesity and its associated diseases. Acta Pharmaceutica Sinica B, 2023; 13(6): 2403-2424.

Hastuti Pramudji. Genetics of obesity. Yogyakarta, Gadjah Mada University Press, 2019; 90.

Freeman AM, Pennings N. Insulin resistance. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing, 2023. Available from: https://www.ncbi.nlm.nih.gov/books/NBK507839/ (accessed Sep 20, 2022).

Lee SH, Park SY, Choi CS. Insulin resistance: From mechanisms to therapeutic strategies. Diabetes Metab J, 2022; 46(1): 15-37.

Kurniawan LB, Bahrun U, Hatta M, Arif M. Body mass, total body fat percentage, and visceral fat level predict insulin resistance better than waist circumference and body mass index in healthy young male adults in Indonesia. J Clin Med. 2018; 7(5): 96.

Perkeni. Guidelines for the management of dyslipidemia in Indonesia 2021. PB Perkeni, 2021; 5.

He H, Feng J, Zhang S, Wang Y, Li J, et al. The apolipoprotein B/A1 ratio is associated with metabolic syndrome components, insulin resistance, androgen hormones, and liver enzymes in women with polycystic ovary syndrome. Front Endocrinol (Lausanne), 2022; 12: 773781.

Kumari NS, Shetty SS. Correlation between ApoB100/ApoA1 ratio and insulin resistance in type 2 diabetes: Apolipoproteins and type 2 diabetes mellitus. Asian Journal of Pharmaceutical and Clinical Research, 2020; 13(2): 79-83.

Gao L, Zhang Y, Wang X, Dong H. Association of apolipoproteins A1 and B with type 2 diabetes and fasting blood glucose: a cross-sectional study. BMC Endocr Disord, 2021; 21(1): 59.

Sutanto K, Idawati Karjadidjaja. The relationship between central obesity and the incidence of dyslipidemia in Tarumanagara University employees visiting the Tarumanagara University Medical Faculty Polyclinic November 2016-April 2017. Tarumanagara Medical Journal, 2019; 1(2):352-360.

Feingold KR. Obesity and Dyslipidemia. [Updated 2023 Jun 19]. In: Feingold KR, Anawalt B, Blackman MR, et al., editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2000-.

Behbodikhah J, Ahmed S, Elyasi A, Kasselman LJ, De Leon J, et al. Apolipoprotein B and cardiovascular disease: Biomarker and potential therapeutic target. Metabolites, 2021; 11(10): 690.

Afandi MR, Marpaung FR. Correlation between apoprotein B/apoprotein AI ratio with HOMA-IR value (Homeostatic Model Assessment of Insulin Resistance) in type 2 diabetes Mellitus. Journal of Vocational Health Studies, 2019; 3(2): 78-82.

Kansal S, Kamble TK. Lipid profile in prediabetes. J Assoc Physicians India, 2016; 64(3): 18-21.

Behiry EG, El Nady NM, AbdEl Haie OM, Mattar MK, Magdy A. Evaluation of TG-HDL ratio instead of HOMA ratio as insulin resistance marker in overweight and children with obesity. Endocr Metab Immune Disord Drug Targets, 2019; 19(5): 676-682.

Lestari PHP, Nurahmi, Esa T, Kurniawan LB. Analysis of the ratio of lipid profiles to total cholesterol, High Density Lipoprotein (HDL), Low Density Lipoprotein (LDL), and triglycerides in Type 2 Diabetes Mellitus (DM-2) patients) with and without diabetic foot ulcer complications. Digest of Medical Science, 2020; 11(3): 1333-1340.

Kohli A, Siddhu A, Pandey RM, Reddy KS. Relevance of the triglyceride-to-high-density lipoprotein cholesterol ratio as an important lipid fraction in apparently healthy, young, and middle-aged Indian men. Indian J Endocrinol Metab, 2017; 21(1): 113-118. 22. Ormazabal V, Nair S, Elfeky O, Aguayo C, Salomon C, et al. Association between insulin resistance and the development of cardiovascular disease. Cardiovascular Diabetic, 2018; 17(1): 122.

Bjornstad P, Eckel RH. Pathogenesis of lipid disorders in insulin resistance: A brief review. Curr Diab Rep, 2018; 18(12): 127.

Downloads

Submitted

2023-06-14

Accepted

2023-08-04

Published

2023-11-03

How to Cite

[1]
Palloge, A.H., Kurniawan, L.B., Widyaningsih, Y., Umar, H., Nurahmi, N. and Zainuddin, A.A. 2023. Correlation of Lipid Profile and Apolipoprotein B/A-I Ratio with Insulin Resistance in Non-Diabetes Mellitus Subjects. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 30, 1 (Nov. 2023), 6–11. DOI:https://doi.org/10.24293/ijcpml.v30i1.2198.

Issue

Section

Articles